
PFRMAT AL
TARGET T0109
AUTHOR 3654-9178-1524
METHOD bioinbgu seqpmprf
MODEL  2
PARENT 4tmk_A
REMARK  hh    hhhhhhhhhhhhhhh      bbbb    hhhhhhhhhhhhhhh
REMARK  KASKLTERAAELQTLDFLKKWVPKGASPICGNSIAQDKRFLVKYMPDLAD
REMARK           | | ||                           |       
REMARK  QGGGRGIDQAMLATLRDAVLGDFRPDLTLY...LDVTPEVGLKRARARGE
REMARK  h      hhhhhhhhhhhhhh     bbbb   bb hhhhhhhhhhhhh 
REMARK  hh       hhhhhhhhhhhhhhhhh          hhhhhhhhhhhhhh
REMARK  YFHYRHLDVSTLKELAARWKPEILEGFK......KENTHLALDDIRESIK
REMARK                  ||                        | ||    
REMARK  LDRIEQESFDFFNRTRARYLELAAQDKSIHTIDATQPLEAVMDAIRTTVT
REMARK         hhhhhhhhhhhhhhhhhh  bbbbbbb  hhhhhhhhhhhhhh
REMARK  hh
REMARK  EL
REMARK    
REMARK  HW
REMARK  hh
REMARK TARGET  FROM-TO   FOLD       FROM-TO  ALIG No.
REMARK TALIGN SEQ 0    76 105  4TMK - 0    107 136  1.0 1
I 75 Y 108
K 76 Q 109
A 77 G 110
S 78 G 111
K 79 G 112
L 80 R 113
T 81 G 114
E 82 I 115
R 83 D 116
A 84 Q 117
E 86 M 119
L 87 L 120
Q 88 A 121
T 89 T 122
L 90 L 123
D 91 R 124
F 92 D 125
L 93 A 126
K 94 V 127
K 95 L 128
W 96 G 129
V 97 D 130
P 98 F 131
K 99 R 132
G 100 P 133
A 101 D 134
S 102 L 135
P 103 T 136
I 104 L 137
REMARK TALIGN SEQ 0   109 153  4TMK - 0    137 181  1.0 1
S 108 Y 138
I 109 L 139
A 110 D 140
Q 111 V 141
D 112 T 142
K 113 P 143
R 114 E 144
F 115 V 145
L 116 G 146
V 117 L 147
K 118 K 148
Y 119 R 149
M 120 A 150
P 121 R 151
D 122 A 152
L 123 R 153
A 124 G 154
D 125 E 155
Y 126 L 156
F 127 D 157
H 128 R 158
Y 129 I 159
R 130 E 160
H 131 Q 161
L 132 E 162
D 133 S 163
V 134 F 164
S 135 D 165
T 136 F 166
L 137 F 167
K 138 N 168
E 139 R 169
L 140 T 170
A 141 R 171
A 142 A 172
R 143 R 173
W 144 Y 174
K 145 L 175
P 146 E 176
E 147 L 177
I 148 A 178
L 149 A 179
E 150 Q 180
G 151 D 181
F 152 K 182
REMARK TALIGN SEQ 0   154 171  4TMK - 0    188 205  1.0 1
K 153 A 189
K 154 T 190
E 155 Q 191
N 156 P 192
T 157 L 193
H 158 E 194
L 159 A 195
A 160 V 196
L 161 M 197
D 162 D 198
D 163 A 199
I 164 I 200
R 165 R 201
E 166 T 202
S 167 T 203
I 168 V 204
K 169 T 205
E 170 H 206
TER
END

